Today: 17 April 2026
IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings

IBM Stock Gets Citi Buy Call Despite Worst Start Since 2002 as BofA Cuts Target Ahead of Earnings

New York, April 13, 2026, 11:37 EDT

IBM ticked up Monday, gaining about 0.9% to $232.78 in late morning New York action, after Citi Research began coverage with a Buy and set a $285 target. Bank of America, on the other hand, dialed back its own target to $300 just ahead of IBM’s quarterly numbers. Despite today’s move, the stock remains down almost 22% for the year.

IBM faces a dual test here: Wall Street wants to see if enterprise AI demand translates into consistent software gains, and analysts are also sizing up the risk that next-gen AI might erode revenue from IBM’s legacy platforms. Eyes turn to April 22, when Q1 numbers hit and investors get their first look at how last month’s Confluent deal is shaking out.

Barron’s noted that Citi’s Fatima Boolani initiated coverage on IBM following its roughest yearly kickoff since 2002, highlighting the tech giant’s entrenched role in global IT and what she called “unusual” customer stickiness. Boolani, according to Barron’s, also pointed to IBM’s lighter capital requirements compared to the cloud hyperscalers, and flagged the company’s quantum roadmap—IBM claims it’s on track for a fault-tolerant quantum system by 2029. Barron’s

Wamsi Mohan at BofA opted for a cautious approach, trimming his price target on the stock to $300 from $340 but sticking with a Buy. He expects Confluent to tack on about $50 million in first-quarter revenue after the March 17 close. Still, he warned, a full quarter of acquisition dilution probably drags down second-quarter earnings per share—a key profit metric.

BofA expects IBM to stick with its 2026 outlook, while attention shifts to how Confluent integration plays out, what’s happening with Red Hat, and whether software and consulting growth holds up. The bank flagged 2026 as a quieter year, with IBM working through the acquisition and investors still uneasy about AI potentially replacing jobs done by traditional software providers.

IBM’s latest numbers give it something to talk about. Back in January, Reuters noted the company topped fourth-quarter expectations, pulling in $19.69 billion in revenue and reporting adjusted earnings of $4.52 per share—boosted by AI-driven software sales. Software revenue hit $9.03 billion. The AI business alone climbed to $12.5 billion, but IBM said it won’t be disclosing that particular figure starting with the first quarter.

The Confluent acquisition is a central plank in IBM’s strategy. After the $11 billion deal closed on March 17, software head Rob Thomas argued, “AI decisions need to happen just as fast” as the underlying transactions. Principal analyst Sanjeev Mohan put it differently, noting AI agents require “live operational signals”—not just old data. According to IBM, the platform’s role is to supply real-time data for AI models, agents, and automated workflows running across hybrid cloud environments. IBM Newsroom

The pressure hasn’t eased. Last week, Reuters noted the S&P 500 Software and Services Index has tumbled 25.5% in 2026, with Adobe, Salesforce, and Intuit all dragged down by renewed worries over AI-driven disruption. IBM got hit hard too—back in February, its shares suffered their sharpest single-day plunge since 2000 after Anthropic introduced its Claude Code tool, which it claims can overhaul COBOL—the legacy programming language still crucial to IBM mainframes used in banks and government—for “quarters instead of years.” Reuters

The stakes for April 22 are clear. IBM needs to prove that appetite for AI, data products, and consulting can outpace the drag from legacy segments and that it can take in Confluent without eroding margins. “We’re getting back to being concerned about the prior software-specific concerns stemming from AI,” Interactive Brokers’ Steve Sosnick told Reuters last week. JonesTrading’s Michael O’Rourke added that the pace of AI innovation is “exposing the weakness of the current software that’s out there.” Reuters

Despite the reduced target on Monday, BofA is sticking with $300, and Citi holds at $285—both higher than where IBM currently trades. The company is scheduled to report after the bell on April 22.

Stock Market Today

  • Kailera Therapeutics Raises $625M in Largest Biotech IPO Since 2018 to Advance Obesity Pipeline
    April 17, 2026, 5:53 AM EDT. Kailera Therapeutics has raised $625 million in its initial public offering (IPO), marking the largest biotech IPO since Moderna's 2018 debut. The Waltham, Massachusetts-based company sold 39 million shares priced at $16 each on the Nasdaq under the ticker KLRA. Funds will chiefly support development of obesity therapies, including injectable and oral GLP-1 drugs licensed from Jiangsu Hengrui Pharmaceuticals. Kailera plans to invest $625 million in late-stage trials for ribupatide, which showed nearly 18% weight loss in China. Additional money will back phase 3 studies of a daily oral version and other pipeline assets. The company may raise another $93 million if underwriters fully exercise their option. Led by CEO Ron Renaud, Kailera aims to compete in the expanding obesity treatment market with a deep late-stage portfolio.

Latest article

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

17 April 2026
Gold hovered near $4,784 an ounce Friday, set for a fourth weekly gain despite easing 0.1% by 0815 GMT. A 10-day Lebanon-Israel ceasefire and possible U.S.-Iran talks kept investors watching for diplomatic progress. Indian gold imports stalled as banks await new government authorization, leaving over 5 tons stuck at customs. Spot silver rose 0.7% to $78.97, platinum held steady, and palladium slipped 0.1%.
UK Stock Market Today: FTSE 100 Slips as Oil Cushions London Shares, Workspace Tumbles

UK Stock Market Today: FTSE 100 Slips as Oil Cushions London Shares, Workspace Tumbles

17 April 2026
London’s FTSE 100 fell 0.18% to 10,570.49 on Friday, trailing gains in Paris and Frankfurt as investors grew cautious ahead of Iran conflict talks. Workspace shares plunged 14% after warning of lower 2027 profits. Tesco, easyJet, and Dunelm flagged pressure from the conflict and consumer pullback. Brent crude hovered near $98, supporting oil stocks but keeping broader sentiment fragile.
US Stock Market Before Open Today: S&P 500 Futures Hold Near Records as Oil Falls and Netflix Slumps

US Stock Market Before Open Today: S&P 500 Futures Hold Near Records as Oil Falls and Netflix Slumps

17 April 2026
U.S. stock futures were steady early Friday, with the S&P 500 near record highs as oil fell below $100 on hopes for renewed U.S.-Iran talks. Netflix shares dropped after weak guidance and news that chairman Reed Hastings will not seek re-election. The Nasdaq closed at a record for a 12th straight session Thursday. Treasury yields held near 4.32% as markets bet the Federal Reserve will stay on hold this year.
Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old
Previous Story

Salesforce Stock News: Choreo and Sumitomo Mitsui Cuts Resurface, but the Filings Are Months Old

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk
Next Story

Nebius Stock (NBIS) Jumps as BofA Backs AI Trade, but Downgrade Flags Valuation Risk

Go toTop